Premium
UCF‐101, A Novel Omi/HtrA2 Inhibitor, Protects Against Cerebral Ischemia/Reperfusion Injury in Rats
Author(s) -
Su Danying,
Su Zhiqiang,
Wang Jiaye,
Yang Shanshan,
Ma Jing
Publication year - 2009
Publication title -
the anatomical record: advances in integrative anatomy and evolutionary biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.678
H-Index - 62
eISSN - 1932-8494
pISSN - 1932-8486
DOI - 10.1002/ar.20910
Subject(s) - tunel assay , neuroprotection , ischemia , medicine , apoptosis , reperfusion injury , pharmacology , western blot , anesthesia , brain ischemia , chemistry , immunohistochemistry , biochemistry , gene
The aim of this study was to investigate the therapeutic efficacy and neuroprotective mechanisms of UCF‐101, a novel Omi/HtrA2 inhibitor, following ischemia/reperfusion brain injury. Male Wistar rats were subjected to 2 hr of middle cerebral artery occlusion followed by reperfusion. Animals were divided into 3 groups: sham, vehicle‐treated ischemia/reperfusion, and UCF‐101 treatment. In the UCF‐101 treatment group, rats were intraperitoneally administered UCF‐101 (1.5 μmol/kg) 10 min prior to reperfusion. The rats were evaluated for neurological deficits, and brain infarct volume was assessed by 2,3,5‐triphenyl tetrazolium chloride. TUNEL staining was utilized to evaluate the amount of apoptosis. In addition, expressions of protein caspase‐8, caspase‐3, FasL, and FLIP were examined by Western blot analysis. Results demonstrated that UCF‐101 treatment significantly decreased cerebral infarct size by about 16.27% ( P < 0.05) and also improved neurological behavior. TUNEL staining revealed that UCF‐101 treatment significantly reduced TUNEL‐positive cells in the cerebral cortex. Furthermore, the upregulation in the expression of FasL and the cleavage products of active caspase‐8 and caspase‐3 induced by ischemia was attenuated in mice treated with UCF‐101, whereas upregulation of FLIP levels was increased. The present results demonstrated that UCF‐101 protects against cerebral ischemia/reperfusion injury in mice. UCF‐101 provided neuroprotection in vivo , and this was correlated with regulation of Fas‐mediated apoptotic proteins. Taken together, the use of UCF‐101 is a potent, neuroprotective factor for the treatment of focal cerebral ischemia. Anat Rec, 292:849–856, 2009. © 2009 Wiley‐Liss, Inc.